Abeona Therapeutics Inc. Common Stock (NASDAQ: ABEO) last traded at $4.38, down 3.10% on the session. The quote above updates while this page is open; the figures below are drawn from Abeona Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Abeona Therapeutics Inc. Common Stock trades on NASDAQ under the ticker ABEO. Its market capitalisation is $250.47 million.
Valuation measures for Abeona Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $250.47M |
|---|---|
| Enterprise value | $245.69M |
| Price / sales | 43.04 |
| Price / book | 1.96 |
| Beta | 1.47 |
Trailing-twelve-month figures tagged in Abeona Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $5.82M |
|---|---|
| Net income (TTM) | -$62.89M |
| EPS (TTM) | -$1.11 |
| Gross margin | 73.68% |
| Operating margin | -1436.68% |
| Return on equity | -49.11% |
| Cash | $56.23M |
Range and volume for ABEO over the past 52 weeks.
| 52-week high | $7.65 |
|---|---|
| 52-week low | $4.00 |
| Volume | 1.22M |
| Average volume | 1.38M |
| Previous close | $4.52 |
Invest a chosen dollar amount in Abeona Therapeutics Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ABEO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.